•
Jun 30, 2020

Gentex Q2 2020 Earnings Report

Gentex experienced a significant decline in sales and profitability due to the COVID-19 pandemic and related shutdowns, but took actions to optimize costs and maintain a strong balance sheet.

Key Takeaways

Gentex reported a 51% decrease in net sales for Q2 2020 compared to Q2 2019, primarily due to the impact of the COVID-19 pandemic on global light vehicle production. The company recognized severance-related costs to achieve annualized savings and maintained positive cash flow from operations. Despite the challenges, Gentex's balance sheet remained strong.

Net sales declined by 51% year-over-year due to COVID-19 impacts on automotive production.

Severance-related costs were recognized to achieve an estimated $35 million in annualized savings.

Positive cash flow from operations of $39.2 million was maintained despite lower sales.

The balance sheet remains strong with $585 million in cash and investments and $75 million in debt.

Total Revenue
$230M
Previous year: $469M
-50.9%
EPS
$0.02
Previous year: $0.42
-95.2%
Gross Profit
$43.9M
Previous year: $177M
-75.1%
Cash and Equivalents
$344M
Previous year: $260M
+32.1%
Total Assets
$2.1B
Previous year: $2.14B
-1.9%

Gentex

Gentex

Gentex Revenue by Segment

Forward Guidance

Gentex expects net sales for the second half of 2020 to be between $865 million and $915 million, with gross margins between 36% and 37%.

Positive Outlook

  • Forecasted improvements in light vehicle production throughout the second half of the year.
  • Significant cost initiatives achieved during the second quarter.
  • Return to more normalized gross and operating margins during the second half of the year.
  • Protecting critical resources necessary to continue the launch of sold programs.
  • Supporting the team that leads research and development.

Challenges Ahead

  • Uncertainty regarding the COVID-19 pandemic.
  • Overall economic conditions globally.
  • Vehicle production trends.
  • Consumer demand for vehicles.
  • Withholding revenue guidance for 2021 until better data becomes available.